|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
We owe a lot to the small community of Bogalusa, Louisiana, and a physician whose work has greatly advanced our knowledge about the progression of heart disease. For three decades, renowned cardiologist Gerald Berenson and his team of researchers have conducted the longest, most detailed study of children in the world; in the process, the Bogalusa Heart Study has provided invaluable insights into the natural history of coronary heart disease and hypertension. Taking Aim at Trans Fats Based on mounting studies linking the health hazards of “nonlisted” trans fat content in foods, the FDA is now mandating that food manufacturers list the man-made trans fat on product labels--a move that health advocates applaud. Focus on Fitness Long commutes, computer-dominated jobs, and communities built without sidewalks or bike trails promote sedentary lifestyles and set the stage for heart disease, diabetes, and obesity. Now, a national health initiative is focusing on ways to help build fitness back into society. Newer Heart Drug Saves Lives In a head-to-head study, heart failure patients taking a new, comprehensive beta-blocker drug lived longer than those prescribed a traditional selective version. The Carvedilol or Metoprolol European Trial (COMET) tested 3,029 patients from 15 European countries and 317 centers over a period of six years. The Cutting Edge of Discovery The world is witnessing an unprecedented pace of medical discovery, aided in part by tremendous advances in genetics and proteomics that are ushering in a new generation of therapies. Dr. Matthias Clauss, a researcher at Indiana Center for Vascular Biology and Medicine and associate professor of cellular and integrative physiology at Indiana University School of Medicine, is on the cutting edge.
|
|
||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
||
|
||
